UK markets open in 54 minutes
NIKKEI 225
38,273.62 -0.43 (-0.00%) HANG SENG
18,200.79 +437.76 (+2.46%) CRUDE OIL
79.50 +0.50 (+0.63%) GOLD FUTURES
2,324.90 +13.90 (+0.60%) DOW
37,903.29 +87.37 (+0.23%) Bitcoin GBP
45,815.38 -1,982.64 (-4.15%)
Myriad Genetics, Inc. (MYGN)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 19.57 |
| Open | 19.74 |
| Bid | 19.44 x 400 |
| Ask | 19.49 x 200 |
| Day's range | 18.83 - 20.03 |
| 52-week range | 13.82 - 24.21 |
| Volume | |
| Avg. volume | 645,562 |
| Market cap | 1.762B |
| Beta (5Y monthly) | 1.98 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Will Myriad Genetics (MYGN) Report Negative Q1 Earnings? What You Should Know
Myriad (MYGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks
Myriad Genetics (MYGN) Announces Favorable Research Results
Myriad Genetics' (MYGN) latest positive initial study outcome is likely to improve clinical outcomes and reduce overall healthcare costs.
- Zacks
Here's Why You Should Retain Myriad Genetics (MYGN) Stock Now
Investors are optimistic about Myriad Genetics' (MYGN) strong solvency position and improvement in testing volume.
© 2024 Yahoo. All rights reserved.